CA2909527A1 - Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines - Google Patents

Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines

Info

Publication number
CA2909527A1
CA2909527A1 CA2909527A CA2909527A CA2909527A1 CA 2909527 A1 CA2909527 A1 CA 2909527A1 CA 2909527 A CA2909527 A CA 2909527A CA 2909527 A CA2909527 A CA 2909527A CA 2909527 A1 CA2909527 A1 CA 2909527A1
Authority
CA
Canada
Prior art keywords
stroke
aminopyridine
impairment
patient
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2909527A
Other languages
English (en)
French (fr)
Inventor
Andrew R. Blight
Anthony O. Caggiano
Tom J. Parry
Jennifer F. Iaci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acorda Therapeutics Inc
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of CA2909527A1 publication Critical patent/CA2909527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2909527A 2013-04-15 2014-04-14 Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines Abandoned CA2909527A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361812239P 2013-04-15 2013-04-15
US61/812,239 2013-04-15
US201361816592P 2013-04-26 2013-04-26
US201361816551P 2013-04-26 2013-04-26
US61/816,592 2013-04-26
US61/816,551 2013-04-26
PCT/US2014/033974 WO2014172266A1 (en) 2013-04-15 2014-04-14 Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines

Publications (1)

Publication Number Publication Date
CA2909527A1 true CA2909527A1 (en) 2014-10-23

Family

ID=50841951

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2909527A Abandoned CA2909527A1 (en) 2013-04-15 2014-04-14 Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines

Country Status (7)

Country Link
US (1) US20160058743A1 (enExample)
EP (3) EP3427735A1 (enExample)
JP (2) JP2016517856A (enExample)
AU (1) AU2014254164A1 (enExample)
CA (1) CA2909527A1 (enExample)
HK (1) HK1221666A1 (enExample)
WO (1) WO2014172266A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009600A1 (en) 1988-04-08 1989-10-19 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
CN101420980A (zh) * 2006-02-16 2009-04-29 菲布罗根公司 治疗中风的化合物和方法
US20100049236A1 (en) * 2008-08-25 2010-02-25 The Ohio State University Research Foundation Method for testing an agent for strokes in humans with a non-human stroke model
JO3348B1 (ar) * 2009-08-11 2019-03-13 Acorda Therapeutics Inc استخدام 4- بايريدين امينو لتحسين الادراك العصبي و/او التلف النفسي لدى مرضى يعانون من نقص النُخاعين وغير ذلك من امراض الجهاز العصبي
US20130030025A1 (en) * 2011-01-28 2013-01-31 Wessel Thomas C Use of potassium channel blockers to treat cerebral palsy
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法

Also Published As

Publication number Publication date
WO2014172266A1 (en) 2014-10-23
AU2014254164A1 (en) 2015-11-05
US20160058743A1 (en) 2016-03-03
HK1221666A1 (zh) 2017-06-09
EP3427735A1 (en) 2019-01-16
JP2016517856A (ja) 2016-06-20
JP2018127497A (ja) 2018-08-16
EP3243516A1 (en) 2017-11-15
EP2986292A1 (en) 2016-02-24

Similar Documents

Publication Publication Date Title
AU2018200114A1 (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
RU2563821C2 (ru) Применение 4-аминопиридина для улучшения состояния при нейрокогнитивном и/или нейропсихиатрическом нарушении у пациентов с демиелинизирующими и другими заболеваниями нервной системы
US20200113883A1 (en) Durable treatment with 4-aminopyridine in patients with demyelination
JP2021519349A (ja) 幻覚とそれに関連する病態の治療のための方法および組成物
US20200230121A1 (en) Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine
CA2909527A1 (en) Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines
TW202302109A (zh) 認知損傷之治療
NZ623255B2 (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
HK1204965B (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
KR20250153297A (ko) 샤르코-마리-투스병의 치료를 위한 조성물 및 방법

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20200831

FZDE Discontinued

Effective date: 20200831